220 related articles for article (PubMed ID: 25061876)
1. Proteasome function is required for platelet production.
Shi DS; Smith MC; Campbell RA; Zimmerman PW; Franks ZB; Kraemer BF; Machlus KR; Ling J; Kamba P; Schwertz H; Rowley JW; Miles RR; Liu ZJ; Sola-Visner M; Italiano JE; Christensen H; Kahr WH; Li DY; Weyrich AS
J Clin Invest; 2014 Sep; 124(9):3757-66. PubMed ID: 25061876
[TBL] [Abstract][Full Text] [Related]
2. RhoA is essential for maintaining normal megakaryocyte ploidy and platelet generation.
Suzuki A; Shin JW; Wang Y; Min SH; Poncz M; Choi JK; Discher DE; Carpenter CL; Lian L; Zhao L; Wang Y; Abrams CS
PLoS One; 2013; 8(7):e69315. PubMed ID: 23935982
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes.
Murai K; Kowata S; Shimoyama T; Yashima-Abo A; Fujishima Y; Ito S; Ishida Y
Eur J Haematol; 2014 Oct; 93(4):290-6. PubMed ID: 24750292
[TBL] [Abstract][Full Text] [Related]
4. Proplatelet generation in the mouse requires PKCε-dependent RhoA inhibition.
Gobbi G; Mirandola P; Carubbi C; Masselli E; Sykes SM; Ferraro F; Nouvenne A; Thon JN; Italiano JE; Vitale M
Blood; 2013 Aug; 122(7):1305-11. PubMed ID: 23838351
[TBL] [Abstract][Full Text] [Related]
5. Rho GTPases and their downstream effectors in megakaryocyte biology.
Pleines I; Cherpokova D; Bender M
Platelets; 2019; 30(1):9-16. PubMed ID: 29913074
[TBL] [Abstract][Full Text] [Related]
6. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes.
Lecine P; Villeval JL; Vyas P; Swencki B; Xu Y; Shivdasani RA
Blood; 1998 Sep; 92(5):1608-16. PubMed ID: 9716588
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
[TBL] [Abstract][Full Text] [Related]
8. The role of platelet factor 4 in radiation-induced thrombocytopenia.
Lambert MP; Xiao L; Nguyen Y; Kowalska MA; Poncz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1533-40. PubMed ID: 21740995
[TBL] [Abstract][Full Text] [Related]
9. Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation.
Mazharian A; Watson SP; Séverin S
Exp Hematol; 2009 Oct; 37(10):1238-1249.e5. PubMed ID: 19619605
[TBL] [Abstract][Full Text] [Related]
10. Hypercholesterolemia impairs megakaryopoiesis and platelet production in scavenger receptor BI knockout mice.
Ouweneel AB; Hoekstra M; van der Wel EJ; Schaftenaar FH; Snip OSC; Hassan J; Korporaal SJA; Van Eck M
Atherosclerosis; 2019 Mar; 282():176-182. PubMed ID: 30278990
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin and bafilomycin A1 alter autophagy and megakaryopoiesis.
Wang Q; You T; Fan H; Wang Y; Chu T; Poncz M; Zhu L
Platelets; 2017 Jan; 28(1):82-89. PubMed ID: 27534900
[TBL] [Abstract][Full Text] [Related]
12. ADAP deficiency impairs megakaryocyte polarization with ectopic proplatelet release and causes microthrombocytopenia.
Spindler M; van Eeuwijk JMM; Schurr Y; Nurden P; Nieswandt B; Stegner D; Reinhold A; Bender M
Blood; 2018 Aug; 132(6):635-646. PubMed ID: 29950291
[TBL] [Abstract][Full Text] [Related]
13. E11/Podoplanin Protein Stabilization Through Inhibition of the Proteasome Promotes Osteocyte Differentiation in Murine in Vitro Models.
Staines KA; Prideaux M; Allen S; Buttle DJ; Pitsillides AA; Farquharson C
J Cell Physiol; 2016 Jun; 231(6):1392-404. PubMed ID: 26639105
[TBL] [Abstract][Full Text] [Related]
14. Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation.
Machlus KR; Thon JN; Italiano JE
Br J Haematol; 2014 Apr; 165(2):227-36. PubMed ID: 24499183
[TBL] [Abstract][Full Text] [Related]
15. Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis.
Pleines I; Hagedorn I; Gupta S; May F; Chakarova L; van Hengel J; Offermanns S; Krohne G; Kleinschnitz C; Brakebusch C; Nieswandt B
Blood; 2012 Jan; 119(4):1054-63. PubMed ID: 22045984
[TBL] [Abstract][Full Text] [Related]
16. Regulation of proplatelet formation and platelet release by integrin alpha IIb beta3.
Larson MK; Watson SP
Blood; 2006 Sep; 108(5):1509-14. PubMed ID: 16670270
[TBL] [Abstract][Full Text] [Related]
17. Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.
Lev PR; Grodzielski M; Goette NP; Glembotsky AC; Espasandin YR; Pierdominici MS; Contrufo G; Montero VS; Ferrari L; Molinas FC; Heller PG; Marta RF
Br J Haematol; 2014 Jun; 165(6):854-64. PubMed ID: 24673454
[TBL] [Abstract][Full Text] [Related]
18. Terminal platelet production is regulated by von Willebrand factor.
Poirault-Chassac S; Nguyen KA; Pietrzyk A; Casari C; Veyradier A; Denis CV; Baruch D
PLoS One; 2013; 8(5):e63810. PubMed ID: 23737952
[TBL] [Abstract][Full Text] [Related]
19. Defective tubulin organization and proplatelet formation in murine megakaryocytes lacking Rac1 and Cdc42.
Pleines I; Dütting S; Cherpokova D; Eckly A; Meyer I; Morowski M; Krohne G; Schulze H; Gachet C; Debili N; Brakebusch C; Nieswandt B
Blood; 2013 Oct; 122(18):3178-87. PubMed ID: 23861250
[TBL] [Abstract][Full Text] [Related]
20. Leukaemia-associated Rho guanine nucleotide exchange factor (LARG) plays an agonist specific role in platelet function through RhoA activation.
Zou S; Teixeira AM; Yin M; Xiang Y; Xavier-Ferrucio J; Zhang PX; Hwa J; Min W; Krause DS
Thromb Haemost; 2016 Aug; 116(3):506-16. PubMed ID: 27345948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
